SYDNEY, Feb 4 (Bernama-GLOBE NEWSWIRE) — George Clinical announces that the organization has been accredited by the Australian Office of the Gene Technology Regulator (OGTR) which allows it to be a licence holder for studies involving the use of genetically modified organisms (GMOs).
The addition of this capability means that George Clinical can now, under the Gene Technology Act 2000 and Gene Technology Regulations 2001, undertake DIR (dealings involving intentional release) and DNIR (dealings not involving intentional release) licensing and execute studies inclusive of the required writing of DIR and DNIR applications as well as IBC (Institutional Biosafety Committee) review. Being OGTR accredited enables George Clinical to hold a license in the name of a sponsoring company.
- Jordan Says Shooting Incident Against Police Patrol “Terrorist Attack”
- 34 Killed, 80 Injured In Barbaric Israeli Airstrikes On Lebanon
- Zionist Israeli Airstrikes Hit Syria-Lebanon Border Crossing: Media
- COP29: Rich nations raise cash offer to $300 billion to poor nations in climate talks
- Iraq Warns Of Possible Israeli Attacks In Letters To UN
- Lee Hsien Loong Supports Lawrence Wong To Lead Singapore’s Ruling Party
- 18 Killed, Over 30 Injured In Armed Clashes In NW Pakistan
- India’s Main Ruling Party BJP-Led Alliance Wins Key State Maharashtra
- Authorities To Deploy Over 10,000 Additional Paramilitary Troopers In India’s Manipur
- Top DPRK Leader Calls For Upgrading Military Equipment